Skip to main content
Top
Published in: Neurocritical Care 3/2013

01-12-2013 | Practical Pearl

Thyroid Hemorrhage Causing Airway Obstruction After Intravenous Thrombolysis for Acute Ischemic Stroke

Authors: Raoul Sutter, Elisabeth Bruder, Mandy Weissenburg, Gianmarco M. Balestra

Published in: Neurocritical Care | Issue 3/2013

Login to get access

Abstract

Background

There are several life-threatening complications associated with intravenous thrombolysis after acute ischemic stroke such as symptomatic intracerebral hemorrhage, orolingual angioedema, or less frequent, bleedings of the mucosa or ecchymosis. Aside from these known critical incidents, rare and unfamiliar complications may be even more challenging, as they are unexpected and may mimic events that appear more frequently. We report a rare and unusual acute complication of intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) (0.9 mg/kg) administered for acute ischemic stroke.

Methods

Medical records, radiologic imaging, and pathologic specimens were reviewed.

Results

A 86-year-old woman developed acute respiratory failure 20 h after thrombolysis with suspected angioedema triggered by intravenous rt-PA. The inspiratory stridor and dyspnea were unresponsive to bronchodilators, corticosteroids, and inhaled adrenaline. After endotracheal intubation, laryngoscopy showed no significant supraglottic narrowing. Thyroidal sonography and cervical computed tomography revealed a thyroidal mass causing a tracheal and vascular compression compatible with thyroidal hemorrhage. Sonography showed a nodular goiter of the right thyroid gland. A total thyroidectomy was performed and histologic analysis confirmed a hemorrhage of the right thyroidal lobe.

Conclusions

Acute airway obstruction with respiratory failure due to thyroidal hemorrhage after intravenous thrombolysis is an important life-threatening complication, mimicking an anaphylactic reaction or a more frequent orolingual angioedema.
Literature
1.
go back to reference Dhand A, Nakagawa K, Nagpal S, Gelfand JM, Kim AS, Smith WS, et al. Cardiac rupture after intravenous t-PA administration in acute ischemic stroke. Neurocrit Care. 2010;13:261–2.PubMedCrossRef Dhand A, Nakagawa K, Nagpal S, Gelfand JM, Kim AS, Smith WS, et al. Cardiac rupture after intravenous t-PA administration in acute ischemic stroke. Neurocrit Care. 2010;13:261–2.PubMedCrossRef
2.
go back to reference Kellert L, Rocco A, Sykora M, Hacke W, Ringleb PA. Frequency of increased blood pressure levels during systemic thrombolysis and risk of intracerebral hemorrhage. Stroke. 2011;42:1702–6.PubMedCrossRef Kellert L, Rocco A, Sykora M, Hacke W, Ringleb PA. Frequency of increased blood pressure levels during systemic thrombolysis and risk of intracerebral hemorrhage. Stroke. 2011;42:1702–6.PubMedCrossRef
3.
go back to reference Brown DL, Barsan WG, Lisabeth LD, Gallery ME, Morgenstern LB. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke. Ann Emerg Med. 2005;46:56–60.PubMedCrossRef Brown DL, Barsan WG, Lisabeth LD, Gallery ME, Morgenstern LB. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke. Ann Emerg Med. 2005;46:56–60.PubMedCrossRef
4.
go back to reference Berger C, Fiorelli M, Steiner T, Schabitz WR, Bozzao L, Bluhmki E, et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke. 2001;32:1330–5.PubMedCrossRef Berger C, Fiorelli M, Steiner T, Schabitz WR, Bozzao L, Bluhmki E, et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke. 2001;32:1330–5.PubMedCrossRef
5.
go back to reference Libman R, Kwiakowski T, Lyden P, Grotta JC, Tilley BC, Fagen SC, et al. Asymptomatic hemorrhagic transformation of cerebral infarction does not worsen long-term outcome. J Stroke Cerebrovasc Dis. 2005;14:50–4.PubMedCrossRef Libman R, Kwiakowski T, Lyden P, Grotta JC, Tilley BC, Fagen SC, et al. Asymptomatic hemorrhagic transformation of cerebral infarction does not worsen long-term outcome. J Stroke Cerebrovasc Dis. 2005;14:50–4.PubMedCrossRef
6.
go back to reference Sloan MA, Sila CA, Mahaffey KW, Granger CB, Longstreth WT Jr, Koudstaal P, et al. Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage. Circulation. 1998;98:1376–82.PubMedCrossRef Sloan MA, Sila CA, Mahaffey KW, Granger CB, Longstreth WT Jr, Koudstaal P, et al. Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage. Circulation. 1998;98:1376–82.PubMedCrossRef
7.
go back to reference Chiu D, Krieger D, Villar-Cordova C, Kasner SE, Morgenstern LB, Bratina PL, et al. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke. 1998;29:18–22.PubMedCrossRef Chiu D, Krieger D, Villar-Cordova C, Kasner SE, Morgenstern LB, Bratina PL, et al. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke. 1998;29:18–22.PubMedCrossRef
8.
go back to reference Jaillard A, Cornu C, Durieux A, Moulin T, Boutitie F, Lees KR, et al. Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. Stroke. 1999;30:1326–32.PubMedCrossRef Jaillard A, Cornu C, Durieux A, Moulin T, Boutitie F, Lees KR, et al. Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. Stroke. 1999;30:1326–32.PubMedCrossRef
9.
go back to reference Hill MD, Lye T, Moss H, Barber PA, Demchuk AM, Newcommon NJ, et al. Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke. Neurology. 2003;60:1525–7.PubMedCrossRef Hill MD, Lye T, Moss H, Barber PA, Demchuk AM, Newcommon NJ, et al. Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke. Neurology. 2003;60:1525–7.PubMedCrossRef
10.
go back to reference Hill MD, Buchan AM. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ. 2005;172:1307–12.PubMedCentralPubMedCrossRef Hill MD, Buchan AM. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ. 2005;172:1307–12.PubMedCentralPubMedCrossRef
11.
go back to reference Onal IK, Dagdelen S, Atmaca A, Karadag O, Adalar N. Hemorrhage into a thyroid nodule as a cause of thyrotoxicosis. Endocr Pract. 2006;12:299–301.PubMedCrossRef Onal IK, Dagdelen S, Atmaca A, Karadag O, Adalar N. Hemorrhage into a thyroid nodule as a cause of thyrotoxicosis. Endocr Pract. 2006;12:299–301.PubMedCrossRef
12.
go back to reference Tsilchorozidou T, Vagropoulos I, Karagianidou C, Grigoriadis N. Huge intrathyroidal hematoma causing airway obstruction: a multidisciplinary challenge. Thyroid. 2006;16:795–9.PubMedCrossRef Tsilchorozidou T, Vagropoulos I, Karagianidou C, Grigoriadis N. Huge intrathyroidal hematoma causing airway obstruction: a multidisciplinary challenge. Thyroid. 2006;16:795–9.PubMedCrossRef
13.
go back to reference Chia PL. Thyroid hemorrhage after thrombolytic therapy for acute myocardial infarction. J Cardiovasc Med (Hagerstown). 2008;9:935–6.CrossRef Chia PL. Thyroid hemorrhage after thrombolytic therapy for acute myocardial infarction. J Cardiovasc Med (Hagerstown). 2008;9:935–6.CrossRef
Metadata
Title
Thyroid Hemorrhage Causing Airway Obstruction After Intravenous Thrombolysis for Acute Ischemic Stroke
Authors
Raoul Sutter
Elisabeth Bruder
Mandy Weissenburg
Gianmarco M. Balestra
Publication date
01-12-2013
Publisher
Springer US
Published in
Neurocritical Care / Issue 3/2013
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-013-9889-z

Other articles of this Issue 3/2013

Neurocritical Care 3/2013 Go to the issue